innovent
Innovent Biologics (HKEX: 01801) is a leading biopharmaceutical company founded in 2011 and headquartered in Suzhou Industrial Park, Jiangsu, China. The company is dedicated to developing, manufacturing, and commercializing high-quality innovative medicines for oncology, metabolic diseases, autoimmune disorders, and other major conditions. Innovent has a vertically integrated R&D and manufacturing platform with over 140,000L of total production capacity and more than 5,600 employees. The company has strategic collaborations with Eli Lilly, Roche, Sanofi, and Incyte. Innovent went public on the Hong Kong Stock Exchange in 2018.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountJan 2025
Nov 2016
Jan 2015
Nov 2012
Jan 2010
Create a free account to see which investors have funded this company.
Create Free Account
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...
Healthcare company applying technology to drug development by building nimble biotech subsidiarie...
Neuralink is building a brain-computer interface for medical needs and greater human potential.
